Hide metadata

dc.date.accessioned2021-03-09T21:16:19Z
dc.date.available2021-03-09T21:16:19Z
dc.date.created2020-08-06T14:06:48Z
dc.date.issued2020
dc.identifier.citationDiener, Hans-Christoph Antonaci, Fabio Braschinsky, Mark Evers, Stefan Jensen, Rigmor Laínez, Jose Miguel Kristoffersen, Espen Saxhaug Tassorelli, Cristina Ryliskiene, Kristina Petersen, Jens A. . European Academy of Neurology guideline on the management of medication-overuse headache. European Journal of Neurology. 2020, 27(7), 1102-1116
dc.identifier.urihttp://hdl.handle.net/10852/83843
dc.description.abstractBackground The frequent use of medication to treat migraine attacks can lead to an increase in migraine frequency and is called medication‐overuse headache (MOH). Methods Based on the available literature in this guideline, the first step in patient management is education and counselling. Results Patients with MOH should be managed by a multidisciplinary team of neurologists or pain specialists and behavioral psychologists. Patients in whom education is not effective should be withdrawn from overused drugs and should receive preventive treatment with drugs of proven efficacy. Patients with MOH in whom preventive treatment is not effective should undergo drug withdrawal. Drug intake can be abruptly terminated or restricted in patients overusing simple analgesics, ergots or triptan medication. In patients with long‐lasting abuse of opioids, barbiturates or tranquilizers, slow tapering of these drugs is recommended. Withdrawal can be performed on an outpatient basis or in a daycare or inpatient setting.
dc.languageEN
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleEuropean Academy of Neurology guideline on the management of medication-overuse headache
dc.typeJournal article
dc.creator.authorDiener, Hans-Christoph
dc.creator.authorAntonaci, Fabio
dc.creator.authorBraschinsky, Mark
dc.creator.authorEvers, Stefan
dc.creator.authorJensen, Rigmor
dc.creator.authorLaínez, Jose Miguel
dc.creator.authorKristoffersen, Espen Saxhaug
dc.creator.authorTassorelli, Cristina
dc.creator.authorRyliskiene, Kristina
dc.creator.authorPetersen, Jens A.
cristin.unitcode185,52,15,0
cristin.unitnameAvdeling for allmennmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.cristin1822051
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=European Journal of Neurology&rft.volume=27&rft.spage=1102&rft.date=2020
dc.identifier.jtitleEuropean Journal of Neurology
dc.identifier.volume27
dc.identifier.issue7
dc.identifier.startpage1102
dc.identifier.endpage1116
dc.identifier.doihttps://doi.org/10.1111/ene.14268
dc.identifier.urnURN:NBN:no-86571
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn1351-5101
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/83843/1/ene.14268.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 4.0 International
This item's license is: Attribution-NonCommercial 4.0 International